Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Liu

Showing results (131-140 of 361) with videos related to

Pageof 37
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferonT W Chang, S McKinney, V Liu, et al.
Applied and Environmental Microbiology|November 27, 2002
Isolation and characterization of metal-reducing thermoanaerobacter strains from deep subsurface environments of the Piceance Basin, ColoradoYul Roh, Shi V Liu, Guangshan Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
Ras activation induces expression of Raet1 family NK receptor ligandsXi V Liu, Samantha S W Ho, James J Tan, et al.
Current Opinion in Chemical Biology|March 13, 2009
Peroxo and oxo intermediates in mononuclear nonheme iron enzymes and related active sitesEdward I Solomon, Shaun D Wong, Lei V Liu, et al.
Expert Opinion on Emerging Drugs|December 21, 2013
Emerging protein kinase inhibitors for non-small cell lung cancerStephen V Liu, Deepa Subramaniam, George C Cyriac, et al.
Journal of Hematology & Oncology|October 26, 2022
Drugging KRAS: current perspectives and state-of-art reviewKaushal Parikh, Giuseppe Banna, Stephen V Liu, et al.
Journal of Hepatology|March 1, 1992
Hepatitis D virus superinfection remains a rare occurrence in non-drug abusers in Hong KongA S Lok, A Wong, S Sporton, et al.
Immunotherapy|October 17, 2025
5-year real-world outcomes with first-line pembrolizumab plus chemotherapy in advanced/metastatic NSCLCStephen V Liu, Riddhi A Babel, Yu-Han Kao, et al.
Chemical Science|May 11, 2013
Mononuclear nickel(II)-superoxo and nickel(III)-peroxo complexes bearing a common macrocyclic TMC ligandJaeheung Cho, Hye Yeon Kang, Lei V Liu, et al.
Clinical Lung Cancer|June 16, 2024
5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-L1 Expression ≥ 50% Advanced NSCLCVamsidhar Velcheti, Pragya Rai, Yu-Han Kao, et al.
Pageof 37

Showing results (131-140 of 361) with videos related to

Sort By:
Pageof 37
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferonT W Chang, S McKinney, V Liu, et al.
Applied and Environmental Microbiology|November 27, 2002
Isolation and characterization of metal-reducing thermoanaerobacter strains from deep subsurface environments of the Piceance Basin, ColoradoYul Roh, Shi V Liu, Guangshan Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
Ras activation induces expression of Raet1 family NK receptor ligandsXi V Liu, Samantha S W Ho, James J Tan, et al.
Current Opinion in Chemical Biology|March 13, 2009
Peroxo and oxo intermediates in mononuclear nonheme iron enzymes and related active sitesEdward I Solomon, Shaun D Wong, Lei V Liu, et al.
Expert Opinion on Emerging Drugs|December 21, 2013
Emerging protein kinase inhibitors for non-small cell lung cancerStephen V Liu, Deepa Subramaniam, George C Cyriac, et al.
Journal of Hematology & Oncology|October 26, 2022
Drugging KRAS: current perspectives and state-of-art reviewKaushal Parikh, Giuseppe Banna, Stephen V Liu, et al.
Journal of Hepatology|March 1, 1992
Hepatitis D virus superinfection remains a rare occurrence in non-drug abusers in Hong KongA S Lok, A Wong, S Sporton, et al.
Immunotherapy|October 17, 2025
5-year real-world outcomes with first-line pembrolizumab plus chemotherapy in advanced/metastatic NSCLCStephen V Liu, Riddhi A Babel, Yu-Han Kao, et al.
Chemical Science|May 11, 2013
Mononuclear nickel(II)-superoxo and nickel(III)-peroxo complexes bearing a common macrocyclic TMC ligandJaeheung Cho, Hye Yeon Kang, Lei V Liu, et al.
Clinical Lung Cancer|June 16, 2024
5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-L1 Expression ≥ 50% Advanced NSCLCVamsidhar Velcheti, Pragya Rai, Yu-Han Kao, et al.
Pageof 37